Innovation Pharmaceuticals Inc (IPIX)

[farrell90]

Thanks for posting

2023:

BASILEA HALF-YEAR REPORT 202318
OUTLOOK:
BASILEA HALF-YEAR REPORT 202318
OUTLOOK pg 18

Upcoming milestones
H2 2023
In-licensing or acquisition of novel anti-infectives
to complement clinical pipeline
H1 2024
In-licensing or acquisition of novel anti-infectives
to complement clinical pipeline

Interesting they are making announcing corporate goal to acquire or license novel, complementary antiinfectives.

I do not know Basilea well enough to outline all the drugs they may be evaluating, but it is a sure bet Brilacidin is one of them.

JMHO, Farrell